Nonenzymatic glycosylation and the pathogenesis of diabetic complications

M. Brownlee, H. Vlassara, A. Cerami

Research output: Contribution to journalArticle

842 Citations (Scopus)

Abstract

Glucose chemically attaches to proteins and nucleic acids without the aid of enzymes. Initially, chemically reversible Schiff base and Amadori product adducts form in proportion to glucose concentration. Equilibrium is reached after several weeks, however, and further accumulation of these early nonenzymatic glycosylation products does not continue beyond that time. Subsequent reactions of the Amadori product slowly give rise to nonequilibrium advanced glycosylation end-products which continue to accumulate indefinitely on longer-lived molecules. Excessive formation of both types of nonenzymatic glycosylation product appears to be the common biochemical link between chronic hyperglycemia and a number of pathophysiologic processes potentially involved in the development of long-term diabetic complications. The major biological effects of excessive nonenzymatic glycosylation include: inactivation of enzymes; inhibition of regulatory molecule binding; crosslinking of glycosylated proteins and trapping of soluble proteins by glycosylated extracellular matrix (both may progress in the absence of glucose); decreased susceptibility to proteolysis; abnormalities of nucleic acid function; altered macomolecular recognition and endocytosis; and increased immunogenicity.

Original languageEnglish (US)
Pages (from-to)527-537
Number of pages11
JournalAnnals of Internal Medicine
Volume101
Issue number4
StatePublished - 1984
Externally publishedYes

Fingerprint

Diabetes Complications
Glycosylation
Glucose
Nucleic Acids
Advanced Glycosylation End Products
Schiff Bases
Extracellular Matrix Proteins
Enzymes
Endocytosis
Hyperglycemia
Proteolysis
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Brownlee, M., Vlassara, H., & Cerami, A. (1984). Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Annals of Internal Medicine, 101(4), 527-537.

Nonenzymatic glycosylation and the pathogenesis of diabetic complications. / Brownlee, M.; Vlassara, H.; Cerami, A.

In: Annals of Internal Medicine, Vol. 101, No. 4, 1984, p. 527-537.

Research output: Contribution to journalArticle

Brownlee, M, Vlassara, H & Cerami, A 1984, 'Nonenzymatic glycosylation and the pathogenesis of diabetic complications', Annals of Internal Medicine, vol. 101, no. 4, pp. 527-537.
Brownlee, M. ; Vlassara, H. ; Cerami, A. / Nonenzymatic glycosylation and the pathogenesis of diabetic complications. In: Annals of Internal Medicine. 1984 ; Vol. 101, No. 4. pp. 527-537.
@article{5d02b259588042039d33f057d7557dc7,
title = "Nonenzymatic glycosylation and the pathogenesis of diabetic complications",
abstract = "Glucose chemically attaches to proteins and nucleic acids without the aid of enzymes. Initially, chemically reversible Schiff base and Amadori product adducts form in proportion to glucose concentration. Equilibrium is reached after several weeks, however, and further accumulation of these early nonenzymatic glycosylation products does not continue beyond that time. Subsequent reactions of the Amadori product slowly give rise to nonequilibrium advanced glycosylation end-products which continue to accumulate indefinitely on longer-lived molecules. Excessive formation of both types of nonenzymatic glycosylation product appears to be the common biochemical link between chronic hyperglycemia and a number of pathophysiologic processes potentially involved in the development of long-term diabetic complications. The major biological effects of excessive nonenzymatic glycosylation include: inactivation of enzymes; inhibition of regulatory molecule binding; crosslinking of glycosylated proteins and trapping of soluble proteins by glycosylated extracellular matrix (both may progress in the absence of glucose); decreased susceptibility to proteolysis; abnormalities of nucleic acid function; altered macomolecular recognition and endocytosis; and increased immunogenicity.",
author = "M. Brownlee and H. Vlassara and A. Cerami",
year = "1984",
language = "English (US)",
volume = "101",
pages = "527--537",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "4",

}

TY - JOUR

T1 - Nonenzymatic glycosylation and the pathogenesis of diabetic complications

AU - Brownlee, M.

AU - Vlassara, H.

AU - Cerami, A.

PY - 1984

Y1 - 1984

N2 - Glucose chemically attaches to proteins and nucleic acids without the aid of enzymes. Initially, chemically reversible Schiff base and Amadori product adducts form in proportion to glucose concentration. Equilibrium is reached after several weeks, however, and further accumulation of these early nonenzymatic glycosylation products does not continue beyond that time. Subsequent reactions of the Amadori product slowly give rise to nonequilibrium advanced glycosylation end-products which continue to accumulate indefinitely on longer-lived molecules. Excessive formation of both types of nonenzymatic glycosylation product appears to be the common biochemical link between chronic hyperglycemia and a number of pathophysiologic processes potentially involved in the development of long-term diabetic complications. The major biological effects of excessive nonenzymatic glycosylation include: inactivation of enzymes; inhibition of regulatory molecule binding; crosslinking of glycosylated proteins and trapping of soluble proteins by glycosylated extracellular matrix (both may progress in the absence of glucose); decreased susceptibility to proteolysis; abnormalities of nucleic acid function; altered macomolecular recognition and endocytosis; and increased immunogenicity.

AB - Glucose chemically attaches to proteins and nucleic acids without the aid of enzymes. Initially, chemically reversible Schiff base and Amadori product adducts form in proportion to glucose concentration. Equilibrium is reached after several weeks, however, and further accumulation of these early nonenzymatic glycosylation products does not continue beyond that time. Subsequent reactions of the Amadori product slowly give rise to nonequilibrium advanced glycosylation end-products which continue to accumulate indefinitely on longer-lived molecules. Excessive formation of both types of nonenzymatic glycosylation product appears to be the common biochemical link between chronic hyperglycemia and a number of pathophysiologic processes potentially involved in the development of long-term diabetic complications. The major biological effects of excessive nonenzymatic glycosylation include: inactivation of enzymes; inhibition of regulatory molecule binding; crosslinking of glycosylated proteins and trapping of soluble proteins by glycosylated extracellular matrix (both may progress in the absence of glucose); decreased susceptibility to proteolysis; abnormalities of nucleic acid function; altered macomolecular recognition and endocytosis; and increased immunogenicity.

UR - http://www.scopus.com/inward/record.url?scp=0021231172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021231172&partnerID=8YFLogxK

M3 - Article

VL - 101

SP - 527

EP - 537

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 4

ER -